- Home
- ORGO vs LTRX Comparison
ORGO vs LTRX Comparison
Compare ORGO & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORGO | LTRX |
|---|---|---|
| Founded | 1985 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Communications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.8M | 296.2M |
| IPO Year | 2016 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ORGO | LTRX |
|---|---|---|
| Price | $2.36 | $5.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $8.50 | $6.50 |
| AVG Volume (30 Days) | 709.8K | ★ 1.5M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1600.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $564,169,000.00 | $122,923,000.00 |
| Revenue This Year | N/A | $1.12 |
| Revenue Next Year | $26.27 | $15.27 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $2.04 | $2.86 |
| 52 Week High | $7.08 | $8.75 |
Technical Indicators
Market Signals| Indicator | ORGO | LTRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.20 | 38.29 |
| Support Level | $2.26 | $5.05 |
| Resistance Level | $2.58 | $5.73 |
| Average True Range (ATR) | 0.11 | 0.48 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 18.75 | 13.39 |
Price Performance
Historical ComparisonAbout ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.